PacBio · 16 hours ago
Engineer II, Mechanical
PacBio is a premier life science technology company focused on advanced sequencing solutions to enhance human health. The NPI Mechanical Engineer II will support new product introduction, ensuring efficient transitions from design to manufacturing while collaborating with various teams to improve product performance and manufacturability.
BiotechnologyChemicalGeneticsLife ScienceMedical
Responsibilities
Lead and execute NPI activities to ensure seamless product transitions from R&D to full-scale manufacturing
Support instrument and sub-assembly builds, troubleshooting, and root cause analysis to improve yield and reliability
Create, review, and release detailed engineering drawings, specifications, and BOM structures
Design, validate, and document packaging for instruments and spare parts to meet quality and compliance standards
Develop and implement scalable manufacturing processes and process control documentation
Collaborate with Contract Manufacturing partners on training, issue resolution, and ongoing quality improvements
Drive mechanical design, prototyping, integration, testing, and final product release activities
Qualification
Required
Bachelor's degree in Mechanical Engineering or a minimum of 4–6 years of relevant industry experience in mechanical design, manufacturing engineering, or new product introduction
Proven hands-on experience in equipment assembly and/or hardware repair
Ability to work independently with minimal supervision
Excellent interpersonal, written, and verbal communication skills
Excellent documentation skills with attention to detail and quality
Results-driven mindset with a demonstrated desire to grow into roles with greater responsibility
Company
PacBio
PacBio is a biotechnology company that designs, develops, and manufactures sequencing systems.
Funding
Current Stage
Public CompanyTotal Funding
$1.96BKey Investors
SoftBankDeerfieldMaverick Ventures
2023-08-17Post Ipo Equity· $85M
2023-06-23Post Ipo Debt· $441M
2023-01-24Post Ipo Equity· $175M
Recent News
2026-01-13
2026-01-13
Company data provided by crunchbase